Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. Oct 15, 2026; 18(10): 120941
Published online Oct 15, 2026. doi: 10.4251/wjgo.120941
Published online Oct 15, 2026. doi: 10.4251/wjgo.120941
Figure 5 Expression of miR-4770 in colorectal cancer cells and its regulation of PRKAA2.
A: The mRNA levels of miR-4770, METTL3 and PRKAA2 in FHC, HCT116 and SW480 cells were detected by qRT-PCR; B and C: In SW480 cells, qRT-PCR was used to detect the expression of miR-4770 (B) and PRKAA2 (C) in each group, which were divided into NC inhibitor, miR inhibitor, NC mimic and miR mimic; D: Western blot was used to detect the level of PRKAA2 protein in the above four groups of SW480 cells. Data are expressed as mean ± SD and are derived from three independent biological replicates. Statistical difference: aP < 0.01 vs FHC group; bP < 0.05 and cP < 0.01 vs NC inhibitor group; dP < 0.01 vs NC mimic group.
- Citation: Yi BS, Lai HB. miR-4770 promotes colorectal cancer progression by targeting PRKAA2 via m6A modification. World J Gastrointest Oncol 2026; 18(10): 120941
- URL: https://www.wjgnet.com/1948-5204/full/v18/i10/120941.htm
- DOI: https://dx.doi.org/10.4251/wjgo.120941